Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer
about
Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC PatientsAnalysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trialStereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.Salvage stereotactic body radiotherapy for locally recurrent non-small cell lung cancer after sublobar resection and i(125) vicryl mesh brachytherapy.The Globalization of Cooperative Groups.Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapyA Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032).Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance)Treatment of stage I lung cancer in high-risk and inoperable patients: SBRT vs. RFA vs. sublobar resection.MDT lung cancer care: input from the Surgical Oncologist.High- and low-dose-rate intraoperative radiotherapy for thoracic malignancies resected with close or positive margins.SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?The potential role of brachytherapy in the irradiation of patients with lung cancer: a systematic review.Evaluation of the 7th and 8th editions of the AJCC/UICC TNM staging systems for lung cancer in a large North American cohort.Surgical Treatment of Lung Cancer.Surgery SBRT in retrospective analyses: confounding by operability is the elephant in the room
P2860
Q26851601-CD8C2ACE-8159-43D7-8792-9F863350EB6BQ30301122-1F87C736-1B00-4A74-9C5A-2B6F91F66FD6Q30992150-A0AE08CB-0A8A-4588-9304-F19C3C048064Q35591365-4B090ACA-6ED1-4AEB-9349-08053493EAB4Q36119749-BA90911C-BBC2-4CB7-80C3-DF1071A90F5AQ36131115-14E47FBF-E79A-4619-B483-28B5812970D7Q37193622-D5916045-E238-4B1B-9D1C-5A3E80693B16Q37193638-9C4F0222-57D4-4062-919E-863EB444C03AQ37705356-3713C6C5-5F2E-4F9D-8B56-E6074C1F9970Q38522779-39BB2CF9-B564-4A52-815D-CC891CEB27BFQ38716403-618D1128-C69A-4EA0-92D5-8F5ED982C5ABQ38813253-CE382D9E-FB42-47B1-8A17-385D77E4AF47Q39159235-0C3A5EE5-5B61-4612-9A6A-9A9180B967E0Q42366507-ECA91A45-0CB6-40CE-8D32-4B668D75A83BQ54099068-80A0D2F2-4B85-4503-A073-20D924410C6DQ57864954-8FC97697-82A4-4A2C-BFEE-17B8C0A7AFE1
P2860
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Impact of brachytherapy on loc ...... ble non-small-cell lung cancer
@ast
Impact of brachytherapy on loc ...... ble non-small-cell lung cancer
@en
type
label
Impact of brachytherapy on loc ...... ble non-small-cell lung cancer
@ast
Impact of brachytherapy on loc ...... ble non-small-cell lung cancer
@en
prefLabel
Impact of brachytherapy on loc ...... ble non-small-cell lung cancer
@ast
Impact of brachytherapy on loc ...... ble non-small-cell lung cancer
@en
P2093
P2860
P356
P1476
Impact of brachytherapy on loc ...... ble non-small-cell lung cancer
@en
P2093
Angelina D Tan
Benedict D T Daly
Bryan F Meyers
David R Jones
Dwight E Heron
Francis C Nichols
Hiran C Fernando
Joe B Putnam
Rodney J Landreneau
Sandra L Starnes
P2860
P304
P356
10.1200/JCO.2013.53.4115
P407
P577
2014-06-30T00:00:00Z